<DOC>
	<DOCNO>NCT01175564</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability pharmacokinetics single repeat oral dos TC-5214 ( S-mecamylamine ) healthy male Japanese subject .</brief_summary>
	<brief_title>To Investigate Safety , Tolerability Pharmacokinetics TC-5214 Healthy Male Japanese Subjects</brief_title>
	<detailed_description />
	<criteria>Japanese Healthy male ≥20 ≤55 year old inclusive suitable vein cannulation repeat venipuncture Have body mass index ( BMI ) ≥18 ≤27 kg/m2 weigh least 50 kg History clinically significant medical neurologic disease disorder , opinion investigator sponsor , may either put subject risk participation study , influence result subject 's History psychiatric disorder Any clinically significant illness , medical/surgical procedure trauma within 4 week first administration investigational product .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>TC-5214</keyword>
	<keyword>safety</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>single dose</keyword>
	<keyword>repeat dose</keyword>
	<keyword>Japanese</keyword>
	<keyword>healthy subject</keyword>
</DOC>